Tuberculosis in patientes treated with tumor necrosis factor-alpha antagonists living in an endemic area. Is the risk worthwhile? Adriana Rojas-Villarraga, Carlos Andrés Agudelo, Ricardo Pineda-Tamayo … [et.al]

Colaborador(es):

Tipo de material: Texto

TextoIdioma: Español Detalles de publicación: Bogotá, D. C; Instituto Nacional de Salud; 2007Descripción: 159-71; ilus.;tblsTema(s):

Resumen: Tumor necrosis factor alpha antagonists (TNFA) are biological agents to treat chronic inflammatory and autoimmune diseases. However, their use is associated with an increased rate of tuberculosis, endemic mycoses, and intracellular bacterial infections. S

Etiquetas de esta biblioteca: No hay etiquetas de esta biblioteca para este título. Ingresar para agregar etiquetas.

No hay ítems correspondientes a este registro

Tumor necrosis factor alpha antagonists (TNFA) are biological agents to treat chronic inflammatory and autoimmune diseases. However, their use is associated with an increased rate of tuberculosis, endemic mycoses, and intracellular bacterial infections. S

No hay comentarios en este titulo.

para colocar un comentario.